61 related articles for article (PubMed ID: 20656364)
1. PET scans in radiotherapy planning of lung cancer.
De Ruysscher D; Kirsch CM
Radiother Oncol; 2010 Sep; 96(3):335-8. PubMed ID: 20656364
[TBL] [Abstract][Full Text] [Related]
2. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer.
De Ruysscher D; Faivre-Finn C; Moeller D; Nestle U; Hurkmans CW; Le Péchoux C; Belderbos J; Guckenberger M; Senan S;
Radiother Oncol; 2017 Jul; 124(1):1-10. PubMed ID: 28666551
[TBL] [Abstract][Full Text] [Related]
3. Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer.
Ma X; Lee C; Zhang T; Cai J; Wang H; Jiang F; Wu Z; Xie J; Jiang G; Li Z
J Nanobiotechnology; 2021 Sep; 19(1):284. PubMed ID: 34551763
[TBL] [Abstract][Full Text] [Related]
4. Shining a Light: Unveiling Cardiac Risks Using Positron Emission Tomography Imaging in Lung Cancer Radiotherapy.
Finazzi T; Putora PM
JCO Clin Cancer Inform; 2024 Apr; 8():e2400045. PubMed ID: 38603639
[No Abstract] [Full Text] [Related]
5. PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.
Konert T; Vogel W; MacManus MP; Nestle U; Belderbos J; Grégoire V; Thorwarth D; Fidarova E; Paez D; Chiti A; Hanna GG
Radiother Oncol; 2015 Jul; 116(1):27-34. PubMed ID: 25869338
[TBL] [Abstract][Full Text] [Related]
6. A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction-A Technical Feasibility and Stability Study.
Bundschuh L; Prokic V; Guckenberger M; Tanadini-Lang S; Essler M; Bundschuh RA
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328128
[TBL] [Abstract][Full Text] [Related]
7. PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients.
Pellegrino S; Fonti R; Pulcrano A; Del Vecchio S
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33573333
[TBL] [Abstract][Full Text] [Related]
8. Analyses of regional radiosensitivity of white matter structures along tract axes using novel white matter segmentation and diffusion imaging biomarkers.
Houri J; Karunamuni R; Connor M; Pettersson N; McDonald C; Farid N; White N; Dale A; Hattangadi-Gluth JA; Moiseenko V
Phys Imaging Radiat Oncol; 2018 Apr; 6():39-46. PubMed ID: 33458387
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy.
Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends.
Maciejczyk A; Skrzypczyńska I; Janiszewska M
Rep Pract Oncol Radiother; 2014 Nov; 19(6):353-60. PubMed ID: 25337407
[TBL] [Abstract][Full Text] [Related]
12. Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitis.
Su Q; Wang D; Yuan B; Liu F; Lei Y; Li S
Cell Biochem Biophys; 2014 Nov; 70(2):1113-7. PubMed ID: 24858285
[TBL] [Abstract][Full Text] [Related]
13. FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2).
Vera P; Mezzani-Saillard S; Edet-Sanson A; Ménard JF; Modzelewski R; Thureau S; Meyer ME; Jalali K; Bardet S; Lerouge D; Houzard C; Mornex F; Olivier P; Faure G; Rousseau C; Mahé MA; Gomez P; Brenot-Rossi I; Salem N; Dubray B
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1057-65. PubMed ID: 24562641
[TBL] [Abstract][Full Text] [Related]
14. Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.
van Elmpt W; Das M; Hüllner M; Sharifi H; Zegers K; Reymen B; Lambin P; Wildberger JE; Troost EGC; Veit-Haibach P; De Ruysscher D
Radiother Oncol; 2013 Oct; 109(1):65-70. PubMed ID: 24044795
[TBL] [Abstract][Full Text] [Related]
15. The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.
Chen HH; Lee BF; Su WC; Lai YH; Chen HY; Guo HR; Yao WJ; Chiu NT
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1478-85. PubMed ID: 23744342
[TBL] [Abstract][Full Text] [Related]
16. Emission guided radiation therapy for lung and prostate cancers: a feasibility study on a digital patient.
Fan Q; Nanduri A; Mazin S; Zhu L
Med Phys; 2012 Nov; 39(11):7140-52. PubMed ID: 23127105
[TBL] [Abstract][Full Text] [Related]
17. Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.
Walter F; la Fougère C; Belka C; Niyazi M
Front Oncol; 2012; 2():130. PubMed ID: 23061046
[No Abstract] [Full Text] [Related]
18. Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.
Goldsmith C; Gaya A
Cancer Imaging; 2012 Sep; 12(2):351-60. PubMed ID: 23023165
[TBL] [Abstract][Full Text] [Related]
19. Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer.
van Elmpt W; Ollers M; Dingemans AM; Lambin P; De Ruysscher D
J Nucl Med; 2012 Oct; 53(10):1514-20. PubMed ID: 22879081
[TBL] [Abstract][Full Text] [Related]
20. Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
Bundschuh RA; Andratschke N; Dinges J; Duma MN; Astner ST; Brügel M; Ziegler SI; Molls M; Schwaiger M; Essler M
Strahlenther Onkol; 2012 Jul; 188(7):592-8. PubMed ID: 22441441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
